【0】学会指南链接：药物性肝损伤
引言 

【1】中国

【2】 中国药物性肝损伤诊治指南

【3】 药物性肝损伤基层诊疗指南

【4】 药物性肝损伤基层诊疗指南(实践版·2019)

【5】 抗结核药物性肝损伤诊治指南

【6】美国

【7】 American Association for the Study of Liver Diseases (AASLD): Practice guidance on drug, herbal, and dietary supplement-induced liver injury 

【8】 American College of Gastroenterology (ACG): Clinical guideline for the diagnosis and management of idiosyncratic drug-induced liver injury 

【9】 AASLD: Position paper for the management of acute liver failure, update 2011 (published 2012)

【10】 American Thoracic Society (ATS): An official statement on the hepatotoxicity of antituberculosis therapy 

【11】欧盟

【12】 European Association for the Study of the Liver (EASL): Clinical practice guidelines on drug-induced liver injury 

【13】 EASL: Clinical practical guidelines on the management of acute (fulminant) liver failure 

【14】印度

【15】 Indian National Association for the Study of the Liver (INASL): Consensus statement on acute liver failure (Part 1) – Epidemiology, pathogenesis, presentation, and prognosis 

【16】 INASL: Consensus statement on acute liver failure (Part 2) – Management of acute liver failure王磊

====================================================================================================
